ADC Therapeutics SA— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$323M
↑+0.4% +$1Mvs FY2024
Total Liabilities
$509M
↓-3.0% -$16Mvs FY2024
Cash
$261M
↑+4.2% +$10Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $323M | $322M |
| Current Assets | $306M | $291M |
| Cash | $261M | $251M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $4M | $2M |
| Other Current | $41M | $38M |
| Non-Current Assets | $17M | $31M |
| PPE | $0 | $5M |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $17M | $26M |
| Total Liab+Eq | $323M | $322M |
| Current Liab. | $70M | $80M |
| Accounts Payable | $9M | $18M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $61M | $62M |
| Non-Current Liab. | $439M | $444M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $439M | $444M |
| Equity | $-186M | $-203M |
| Retained Earnings | $1.64B | $1.49B |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · ADCT · Comparing FY2025 vs FY2024